PMA device
coflex Interlaminar Stabilization Device
Companion Spine France · Prosthesis, Spinous Process Spacer/Plate (NQO, Class III) · First FDA decision Apr 7, 2020, newest Mar 31, 2021Degenerative disc disease and spinal stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
3
Naming "coflex Interlaminar Stabilization"
MAUDE reports
0
Brand "coflex Interlaminar Stabilization", since 2015
PubMed studies
15
Mentioning "coflex Interlaminar Stabilization"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing coflex Interlaminar Stabilization Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- coflex Interlaminar Stabilization DevicePMA supplement
P110008-S013 · Decided Mar 31, 2021 · 84 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
- coflex Interlaminar Stabilization DevicePMA supplement
P110008-S011 · Decided Apr 7, 2020 · 161 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "coflex Interlaminar Stabilization", any status and sponsor, newest update first.
Companion Spine, LLCAcademic, hospital or other
NCT02555280 · 40 participants · Start Sep 9, 2019 · Primary completion May 31, 2026
Device: coflex® Interlaminar Technology · For: Spinal Stenosis Lumbar
Sites: Phoenix, Arizona; Sacramento, California; San Luis Obispo, California · 14 sites in all
- Clinical Trial Comparing Decompression With and Without Coflex™ Interlaminar Technology Treating Lumbar Spinal StenosisPivotal-lookingCompleted
Paradigm SpineNot on our public-company list
NCT01316211 · 246 participants · Start Jan 2008 · Primary completion Aug 2014
Device: Implantation of coflex™ after surgical decompression · For: Spinal Stenosis
Sites: Potsdam, Germany; Frankfurt a.M., Germany; Rostock, Germany · 8 sites in all
Predicted, Reported and Observed Outcomes FoundationAcademic, hospital or other
NCT02457468 · 325 participants · Start Jun 2015 · Primary completion Dec 2019
Device: coflex · For: Spinal Stenosis
Sites: Phoenix, Arizona; Scottsdale, Arizona; Tucson, Arizona · 28 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "coflex Interlaminar Stabilization", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NQO
2,342 reports: 1,410 malfunction, 926 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "coflex Interlaminar Stabilization"[tiab]. The summary above synthesizes these.
- Application of the Coflex Interlaminar Stabilization in Patients With L5/S1 Degenerative Diseases: Minimum 4-Year Follow-up.
Xu C, Mao F, Wang X, et al. · Am J Ther · 2016
- A novel strategy of non-fusion instrumentation with coflex interlaminar stabilization after decompression for lumbar spinal stenosis.
Nomura H · J Spine Surg · 2016Editorial, Comment
- Comparison of Coflex dynamic stabilization with bacfuse static stabilization for lumbar degenerative disease.
Chen H, Ding Y, Wang X, et al. · BMC Musculoskelet Disord · 2025Comparative Study
- Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis.
Schmier JK, Halevi M, Maislin G, et al. · Clinicoecon Outcomes Res · 2014
- Decompression and Coflex interlaminar stabilization compared with decompression and instrumented spinal fusion for spinal stenosis and low-grade degenerative spondylolisthesis: two-year results from the prospective, randomized, multicenter, Food and Drug Administration Investigational Device Exemption trial.
Davis RJ, Errico TJ, Bae H, et al. · Spine (Phila Pa 1976) · 2013Comparative Study, Multicenter Study
- Decompression and coflex interlaminar stabilization compared with conventional surgical procedures for lumbar spinal stenosis: A systematic review and meta-analysis.
Kuang MJ, Ma JX, Ma XL · Int J Surg · 2017Letter, Comment
- Therapeutic sustainability and durability of coflex interlaminar stabilization after decompression for lumbar spinal stenosis: a four year assessment.
Bae HW, Lauryssen C, Maislin G, et al. · Int J Spine Surg · 2015
- Chiropractic management of a Veteran with persistent spinal pain syndrome-2 status-post L3-L5 laminectomy and Coflex interlaminar stabilization: a case report.
Joyce JO, Bonavito-Larragoite GM, Cupler ZA · J Can Chiropr Assoc · 2025
- Can low-grade spondylolisthesis be effectively treated by either coflex interlaminar stabilization or laminectomy and posterior spinal fusion? Two-year clinical and radiographic results from the randomized, prospective, multicenter US investigational device exemption trial: clinical article.
Davis R, Auerbach JD, Bae H, et al. · J Neurosurg Spine · 2013Comparative Study, Multicenter Study
- Patient Outcomes After Single-level Coflex Interspinous Implants Versus Single-level Laminectomy.
Zhong J, O'Connell B, Balouch E, et al. · Spine (Phila Pa 1976) · 2021
- Response: "Decompression and coflex interlaminar stabilization compared with conventional surgical procedures for lumbar spinal stenosis: A systematic review and meta-analysis".
Li AM, Li X, Zhong Y · Int J Surg · 2017Letter, Comment
- Three-Year Follow-up of the Prospective, Randomized, Controlled Trial of Coflex Interlaminar Stabilization vs Instrumented Fusion in Patients With Lumbar Stenosis.
Bae HW, Davis RJ, Lauryssen C, et al. · Neurosurgery · 2016Comparative Study, Multicenter Study
Other devices of this type
Also filed under product code NQO.
- Superion Indirect Decompression SystemBoston Scientific Neuromodulation · PMA 2024
- coflex® Interlaminar TechnologyCompanion Spine France · PMA 2026
- X-Stop Interspinous Spacer SystemMedtronic Sofamor Danek, Inc. · PMA 2012
- Superion Interspinous SpacerBoston Scientific Neuromodulation · PMA 2017
- X Stop Interspinous Process Decompression SystemMedtronic Sofamor Danek, Inc. · PMA 2006
- DIAM Spinal Stabilization SystemCompanion Spine France Sas · PMA 2025
- Paradigm Spine Coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2018
- X-Stop LtosMedtronic Sofamor Danek, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.